Inventor · disambiguated record
Svitlana Garbuzova-Davis
Also filed as: GARBUZOVA-DAVIS SVITLANA
6 granted patents·1 pending application·1 citations·filing 2005–2023
66Inventor score
Top patents by PatentIndex Score
7 records- 0169US12144832B1Plasma derived from human umbilical cord blood for the treatment of neurodegenerative disordersUNIV SOUTH FLORIDA·Filed 2023·Granted Nov 19, 2024·0 cites·3 claims
- 0269US11007230B1Plasma derived from human umbilical cord blood for the treatment of neurodegenerative disordersGARBUZOVA DAVIS SVITLANA·Filed 2016·Granted May 18, 2021·1 cites·10 claims
- 0364US11628190B2Plasma derived from human umbilical cord blood for the treatment of neurodegenerative disordersGARBUZOVA DAVIS SVITLANA·Filed 2019·Granted Apr 18, 2023·0 cites·6 claims
- 0459US9173907B2Method of prenatal administration of mammalian umbilical cord stem cells for the intrauterine treatment of sanfilippo syndromeGARBUZOVA-DAVIS SVITLANA·Filed 2008·Granted Nov 3, 2015·0 cites·10 claims
- 0544US2018250341A1Method of repairing damaged blood-spinal cord barrier (bscb)GARBUZOVA DAVIS SVITLANA·Filed 2018·Application pending·0 cites
- 0642US8765119B2Treating amyotrophic lateral sclerosis (ALS)with isolated aldehyde dehydrogenase-positive umbilical cord blood cellsGARBUZOVA-DAVIS SVITLANA·Filed 2005·Granted Jul 1, 2014·0 cites·10 claims
- 0735US10285935B2Non-invasive method for direct delivery of therapeutics to the spinal cord in the treatment of spinal cord pathologyGARBUZOVA DAVIS SVITLANA·Filed 2016·Granted May 14, 2019·0 cites·4 claims
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →